SCA
BIOR

Sassicaia Capital Advisers’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Sassicaia Capital Advisers’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-268
Closed -$102K – 52
2021
Q3 		$102K Buy
+268
New +$115K 0.29% 35

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Sassicaia Capital Advisers's BIOR Position: Q4 2021 in Review

Sassicaia Capital Advisers sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2021, closing a stake of 268 shares — an estimated $102K sold.

Sassicaia Capital Advisers first reported a position in BIOR in Q3 2021 and held it in 1 quarter. The position peaked at $102K in Q3 2021. 53 funds tracked by Wall St. Rank hold BIOR as of Q4 2021.

  • Sassicaia Capital Advisers reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Sassicaia Capital Advisers sold 268 Biora Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $102K.
  • Sassicaia Capital Advisers first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Sassicaia Capital Advisers's Biora Therapeutics, Inc. Common Stock position peaked at $102K in Q3 2021.
  • 53 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Sassicaia Capital Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.